Taser International, Inc. announced it had given up its fight in two major legal battles over “suspect injury or death.” In a 275-word statement submitted to the US Securities and Exchange Commission, the company’s chief financial officer said it would pay a total of $2.3 million in settlements to plaintiffs who had sued the company in product liability cases.
This was rare. Taser prides itself in fighting to the bitter end in any case alleging that its products do anything but save lives. Yet there it was in a financial disclosure — Taser backing down.
According to the vaguely worded Taser statement, enhanced “risk management procedures” and “revisions to product warnings” in 2009 corrected a legal vulnerability. The $2.3 million payouts would address the last lawsuits tied to that vulnerability; they would amount to housekeeping — cleaning up lingering messes that had remained on the company’s books since before 2009.
According to a civil complaint filed in 2010 by Piskura’s parents, an officer ordered Kevin Piskura to “step back or back away” from the fight. It’s not clear whether he did or not, but the officer soon pulled out a Taser ECD and shot Piskura in the chest. Piskura went into cardiac arrest; his heart stopped beating. He was taken to a nearby emergency room and soon life-flighted to a Cincinnati hospital where he died five days later. This past March, Piskura’s parents settled with the City of Oxford and the Oxford Police Department for $750,000. In October, Piskura’s parents suggested they were considering a settlement with Taser.
Kevin Piskura’s death fits a pattern consistent to ongoing product liability cases involving Taser-related incidents in which someone was killed prior to September, 2009. The $2.3 million payouts likely stem from similar cases; these incidents occurred before Taser made its switch from “non-lethal” to “less lethal.”
Regarding that: letters to medical journals and plenty of anecdotal evidence have suggested at least since 2005 that even healthy people could suffer cardiac arrest if shot near the heart with Taser’s “non-lethal” ECDs. By September, 2009, Taser changed its product warnings accordingly. Today, Taser’s ECDs are branded as “less lethal” instead of “non lethal,” and its training materials warn that “exposure in the chest area near the heart … could lead to cardiac arrest.”
Another ongoing cardiac arrest case against Taser involves Ryan Rich. A 33-year-old physician in Las Vegas, Rich went into cardiac arrest and died in January, 2008 after he was shot five times with an ECD, including once in the chest. That case is headed to trial in January.
A third case comes out of the Detroit suburb of Warren, Michigan, and will head to trial in May, 2014. It involves the 2009 death of 16-year-old, 5-feet-2-inch Robert Mitchell, who died in an abandoned house after being shot in the chest by a Warren police officer with a Taser ECD.
Daryl Turner was 17 years old in March 2008 when he got into an argument with his boss at the North Carolina Food Lion grocery where he worked as a cashier. According to a complaint later filed by Turner’s parents, the argument escalated to shouting and Turner’s boss eventually called 911. A police officer from the Charlotte Mecklenburg Police Department arrived and asked Turner to “calm down.” When the teenager refused, the officer pointed his Taser ECD at Turner’s chest. Turner began to step toward the officer, so the officer “held down the Taser’s trigger, causing the device to continue emitting an electrical current, until Turner eventually collapsed 37 seconds after the device initially was activated.” Paramedics soon arrived to find Turner handcuffed and unconscious. He was pronounced dead at the scene.
In an uncommon outcome, Turner’s family was awarded a massive payout in 2011. Taser appealed. In November of this year, an appeals court issued its opinion that Taser should remain liable for Turner’s death, but that the jury’s award needed to be reconsidered. “We have no doubt that Turner had significant value to his parents,” the appeals court’s decision read. But the court couldn’t agree with a “reasonable level of certainty” that the boy’s life was worth $6.15 million. The parties are scheduled to head back to court in 2014 to haggle over that figure. Unless, that is, Taser has decided to cut its losses and settle out of court.
Taser International is very good about keeping records. In addition to its Axon Flex on-body police camera that allows officers to record interactions with suspects, the company also collects data every time a Taser ECD is fired. But it’s up to police departments — and up to Taser International — to decide how much of that information is revealed publicly.
Taser, Inc. takes a similar approach in the courtroom.
Taser typically insists on keeping its legal settlements — such as those referenced in its recent $2.3 million payout — secret. Rarely are the terms made public. But it happens occasionally. One Northern California case involved a drunk man off his psychiatric meds who was shot with a Taser ECD after refusing to get off a bus. He went into cardiac arrest. An emergency crew was able to resuscitate him on scene, but after going 18 minutes without a breath, the man suffered a crippling brain injury. He would require a caregiver from that point forward.
After a long legal battle, Taser agreed to settle that case. As per usual, it demanded that the settlement agreement be kept secret. The defendants in the case agreed. But eventually it was revealed that the company had settled for $2.85 million. The settlement figure was only made public after a probate court judge made the unusual decision to disclose the dollar amount in open court.
A report from the San Jose Mercury News later explained the judge’s reasoning. There was, the judge said, “therapeutic value” in making the information public.
Whether or not a judge makes similar decisions about Taser’s recent settlements, it’s clear that the company has decided to settle cardiac arrest cases as quietly as possible because it has maintained for years that its weapons are effective, non-deadly alternatives to firearms. If too much attention focuses on Taser-related deaths, there’s a risk that police departments might choose to sidestep the controversy altogether and opt against Taser’s products.
There’s a lot at stake on both sides. For Taser, its NASDAQ-traded stock value is on the line. And for those engaged in open legal battles over Taser-related deaths involving cardiac arrest and factors such as “excited delirium” (“a euphemism for ‘death by Taser’“) — as well as those who may literally find themselves facing down a Taser ECD in the future — the value of an open settlement may amount to more than mere therapy. It could amount to life or death.
Death by Taser: the medicine behind the headlines: